January 26, 2022 00:52 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Buddhadev Bhattacharjee wants to be Azad not Ghulam: Jairam Ramesh on Padma Award for party colleague | Ex-Bengal CM Buddhadeb Bhattacharjee refuses Padma Bhushan award | Armed forces will benefit from better gender balance: President Ram Nath Kovind on R-Day eve | General Bipin Rawat, vaccine makers, Buddhadeb Bhattacharjee named for Padma Awards 2022 | Indian youth leading startups both in India, outside: PM Modi
India-made Covishield cleared for travel to United States from November as of now: Reports US travel | Covishield
Representative image of airport/ credit: Unsplash

India-made Covishield cleared for travel to United States from November as of now: Reports

India Blooms News Service | @indiablooms | 21 Sep 2021, 08:14 pm

New Delhi/IBNS: As the United States will allow fully vaccinated air passengers to travel to the country from November, Serum Institute's Covishield has become the only Indian-made vaccine to find a place in the list of approved ones for now, media reports said.

India is also among the 33 countries from where fully vaccinated travellers will be allowed to enter the United States.

From November, the US will admit fully vaccinated air travelers from the 26 so-called Schengen countries in Europe, including France, Germany, Italy, Spain, Switzerland and Greece, as well as Britain, Ireland, China, India, South Africa, Iran and Brazil.

The White House has clarified that the final decision on what vaccines would be accepted will be taken up by the US Centers for Disease Control and Prevention (CDC).

The top medical body of the country has said that it considers a person "fully vaccinated" against coronavirus if they have been jabbed with any FDA-authorised vaccine or any those approved by the World Health Organization (WHO).

Vaccinated passengers will be required to show the proof of vaccination before travel and will not be required to quarantine on arrival.

So far, only seven vaccines have been approved for use by the WHO including Moderna, Pfizer-BioNTech, Johnson & Johnson, Oxford-AstraZeneca, Covishield (an Oxford-AstraZeneca formulation) and China's Sinopharm and Sinovac.

Another Indian-made vaccine 'Covaxin', developed by Bharat Biotech, has not yet been approved by the WHO nor the US FDA.